Sharp decline in investments in Israel's life sciences industry in 2025
A newly published report presents a complex picture of the Health-Tech industry in Israel. While 2024 showed signs of economic recovery, the data for 2025 indicates a significant and concerning trend shift for companies in the sector.
According to the report, there has been a sharp 40% decline in the volume of investments in Israeli life sciences companies during the current year. This is a significant figure that points to the growing difficulty for companies in the field to raise capital from investors, following the positive period recorded last year.
In addition to the overall decline in investments, the report points to a continuing trend of a decrease in the average amount of each deal. This means that companies are receiving less money for each funding round, which could impact their ability to develop new products and continue complex medical research.
Despite the decline in investments, the report notes that exports from the life sciences industry remain relatively stable. This figure indicates that Israeli companies continue to operate and sell their products in international markets, despite the economic challenges within the country.
These data raise questions regarding the future of the industry and its ability to continue leading in technological innovation in the healthcare sector. Market experts will continue to monitor trends in the coming months to understand whether this is a temporary crisis or a long-term change in investment habits in the field.